Toll-like receptor function in primary B cell defects

Frontiers in Bioscience - Elite

Volumn 4 E, Issue 5, 2012, Pages 1853-1863

  Marron, Thomas U ^a   Yu, Joyce E ^a,b   Cunningham Rundles, Charlotte ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

B cell; Common variable immune deficiency; CVID; Review; TLR; Toll like receptors; X linked agammaglobulinemia; XLA

Indexed keywords

B LYMPHOCYTE RECEPTOR; BETA INTERFERON; BRUTON TYROSINE KINASE; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 1; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 4; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 6; MYELOID DIFFERENTIATION FACTOR 88; PLECKSTRIN; THYMUS INDEPENDENT ANTIGEN; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 10; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 6; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR 9; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 1; TRANSMEMBRANE ACTIVATOR AND CAML INTERACTOR; TUMOR NECROSIS FACTOR ALPHA; AGAMMAGLOBULINAEMIA TYROSINE KINASE; PROTEIN TYROSINE KINASE;

ADAPTIVE IMMUNITY; ANTIBODY RESPONSE; ANTIGEN PRESENTING CELL; AUTOIMMUNITY; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; CELL MATURATION; COMMON VARIABLE IMMUNODEFICIENCY; CYTOKINE PRODUCTION; FIRST DEGREE RELATIVE; GENE MUTATION; HUMAN; HUMORAL IMMUNITY; IMMUNOGLOBULIN DEFICIENCY; IMMUNOGLOBULIN PRODUCTION; IMMUNOPHENOTYPING; INNATE IMMUNITY; LYMPHOCYTE ACTIVATION; LYMPHOID HYPERPLASIA; MEMORY CELL; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PLASMACYTOID DENDRITIC CELL; POINT MUTATION; REVIEW; SIGNAL TRANSDUCTION; UPREGULATION; X CHROMOSOME; X LINKED AGAMMAGLOBULINEMIA; AGAMMAGLOBULINEMIA; ANIMAL; ENZYMOLOGY; IMMUNOLOGY; METABOLISM; MOUSE; PHYSIOLOGY; X CHROMOSOME LINKED DISORDER;

AGAMMAGLOBULINEMIA; ANIMALS; B-LYMPHOCYTES; GENETIC DISEASES, X-LINKED; HUMANS; IMMUNOPHENOTYPING; LYMPHOCYTE ACTIVATION; MICE; PROTEIN-TYROSINE KINASES; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS;

EID: 84860866644     PISSN: 19450494     EISSN: 19450508     Source Type: Journal    
DOI: None     Document Type: Review

References (106)

1. M. E. Conley: Hypogammaglobulinemia: fifty years later. Clin Immunol, 104(3), 201-3 (2002) (Pubitemid 35191094)
2. A. Durandy: Hyper-IgM syndromes: a model for studying the regulation of class switch recombination and somatic hypermutation generation. Biochem Soc Trans, 30(4), 815-8 (2002) (Pubitemid 35001666)
3. K. Imai, G. Slupphaug, W. I. Lee, P. Revy, S. Nonoyama, N. Catalan, L. Yel, M. Forveille, B. Kavli, H. E. Krokan, H. D. Ochs, A. Fischer and A. Durandy: Human uracil-DNA glycosylase deficiency associated with profoundly impaired immunoglobulin class-switch recombination. Nat Immunol, 4(10), 1023-8 (2003)
4. J. L. Casanova, C. Fieschi, S. Y. Zhang and L. Abel: Revisiting human primary immunodeficiencies. J Intern Med, 264(2), 115-27 (2008) (Pubitemid 351965489)
5. J. L. Casanova, L. Abel and L. Quintana-Murci: Human TLRs and IL-1Rs in Host Defense: Natural Insights from Evolutionary, Epidemiological, and Clinical Genetics. Annu Rev Immunol, 29, 447-91 (2011)
6. J. Booth, H. Wilson, S. Jimbo and G. Mutwiri: Modulation of B cell responses by Toll-like receptors. Cell Tissue Res, 343(1), 131-40 (2011)
7. V. Hornung, S. Rothenfusser, S. Britsch, A. Krug, B. Jahrsdorfer, T. Giese, S. Endres and G. Hartmann: Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J Immunol, 168(9), 4531-7 (2002)
8. N. L. Bernasconi, N. Onai and A. Lanzavecchia: A role for Toll-like receptors in acquired immunity: upregulation of TLR9 by BCR triggering in naive B cells and constitutive expression in memory B cells. Blood, 101(11), 4500-4 (2003)
9. S. Fillatreau and R. A. Manz: Tolls for B cells. Eur J Immunol, 36(4), 798-801 (2006)
10. C. R. Ruprecht and A. Lanzavecchia: Toll-like receptor stimulation as a third signal required for activation of human naive B cells. Eur J Immunol, 36(4), 810-6 (2006)
11. L. M. Ganley-Leal, Y. Liang, M. Jagannathan-Bogdan, F. A. Farraye and B. S. Nikolajczyk: Differential regulation of TLR4 expression in human B cells and monocytes. Mol Immunol, 48(1-3), 82-8 (2010)
12. A. M. Krieg: CpG motifs in bacterial DNA and their immune effects. Annu Rev Immunol, 20, 709-60 (2002) (Pubitemid 34293438)
13. A. M. Krieg, A. K. Yi, S. Matson, T. J. Waldschmidt, G. A. Bishop, R. Teasdale, G. A. Koretzky and D. M. Klinman: CpG motifs in bacterial DNA trigger direct B-cell activation. Nature, 374(6522), 546-9 (1995)
14. F. Gantner, P. Hermann, K. Nakashima, S. Matsukawa, K. Sakai and K. B. Bacon: CD40-dependent and - independent activation of human tonsil B cells by CpG oligodeoxynucleotides. Eur J Immunol, 33(6), 1576-85 (2003) (Pubitemid 36790418)
15. B. He, X. Qiao and A. Cerutti: CpG DNA induces IgG class switch DNA recombination by activating human B cells through an innate pathway that requires TLR9 and cooperates with IL-10. J Immunol, 173(7), 4479-91 (2004) (Pubitemid 39280678)
16. H. Poeck, M. Wagner, J. Battiany, S. Rothenfusser, D. Wellisch, V. Hornung, B. Jahrsdorfer, T. Giese, S. Endres and G. Hartmann: Plasmacytoid dendritic cells, antigen, and CpG-C license human B cells for plasma cell differentiation and immunoglobulin production in the absence of T-cell help. Blood, 103(8), 3058-64 (2004) (Pubitemid 38451681)
17. A. Aranburu, S. Ceccarelli, E. Giorda, R. Lasorella, G. Ballatore and R. Carsetti: TLR ligation triggers somatic hypermutation in transitional B cells inducing the generation of IgM memory B cells. J Immunol, 185(12), 7293-301 (2010)
18. E. Bourke, D. Bosisio, J. Golay, N. Polentarutti and A. Mantovani: The toll-like receptor repertoire of human B lymphocytes: inducible and selective expression of TLR9 and TLR10 in normal and transformed cells. Blood, 102(3), 956-63 (2003) (Pubitemid 36917790)
19. E. Traggiai, R. Puzone and A. Lanzavecchia: Antigen dependent and independent mechanisms that sustain serum antibody levels. Vaccine, 21 Suppl 2, S35-7 (2003) (Pubitemid 36588647)
20. J. Huggins, T. Pellegrin, R. E. Felgar, C. Wei, M. Brown, B. Zheng, E. C. Milner, S. H. Bernstein, I. Sanz and M. S. Zand: CpG DNA activation and plasma-cell differentiation of CD27- naive human B cells. Blood, 109(4), 1611-9 (2007) (Pubitemid 46239595)
21. L. Lin, A. J. Gerth and S. L. Peng: CpG DNA redirects class-switching towards "Th1-like" Ig isotype production via TLR9 and MyD88. Eur J Immunol, 34(5), 1483-7 (2004) (Pubitemid 39256028)
22. F. Heil, P. Ahmad-Nejad, H. Hemmi, H. Hochrein, F. Ampenberger, T. Gellert, H. Dietrich, G. Lipford, K. Takeda, S. Akira, H. Wagner and S. Bauer: The Tolllike receptor 7 (TLR7)-specific stimulus loxoribine uncovers a strong relationship within the TLR7, 8 and 9 subfamily. Eur J Immunol, 33(11), 2987-97 (2003) (Pubitemid 37428331)
23. I. B. Bekeredjian-Ding, M. Wagner, V. Hornung, T. Giese, M. Schnurr, S. Endres and G. Hartmann: Plasmacytoid dendritic cells control TLR7 sensitivity of naive B cells via type I IFN. J Immunol, 174(7), 4043-50 (2005) (Pubitemid 40395980)
24. M. C. Glaum, S. Narula, D. Song, Y. Zheng, A. L. Anderson, C. H. Pletcher and A. I. Levinson: Toll-like receptor 7-induced naive human B-cell differentiation and immunoglobulin production. J Allergy Clin Immunol, 123(1), 224-230 e4 (2009)
25. A. K. Heer, A. Shamshiev, A. Donda, S. Uematsu, S. Akira, M. Kopf and B. J. Marsland: TLR signaling finetunes anti-influenza B cell responses without regulating effector T cell responses. J Immunol, 178(4), 2182-91 (2007) (Pubitemid 46233416)
26. A. Lanzavecchia, N. Bernasconi, E. Traggiai, C. R. Ruprecht, D. Corti and F. Sallusto: Understanding and making use of human memory B cells. Immunol Rev, 211, 303-9 (2006) (Pubitemid 43882981)
27. S. Akira, K. Takeda and T. Kaisho: Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol, 2(8), 675-80 (2001) (Pubitemid 32747155)
28. C. Pasare and R. Medzhitov: Control of B-cell responses by Toll-like receptors. Nature, 438(7066), 364-8 (2005) (Pubitemid 41643953)
29. H. M. Guay, T. A. Andreyeva, R. L. Garcea, R. M. Welsh and E. Szomolanyi-Tsuda: MyD88 is required for the formation of long-term humoral immunity to virus infection. J Immunol, 178(8), 5124-31 (2007) (Pubitemid 46595296)
30. S. Koyama, K. J. Ishii, H. Kumar, T. Tanimoto, C. Coban, S. Uematsu, T. Kawai and S. Akira: Differential role of TLR- and RLR-signaling in the immune responses to influenza A virus infection and vaccination. J Immunol, 179(7), 4711-20 (2007)
31. A. L. Gavin, K. Hoebe, B. Duong, T. Ota, C. Martin, B. Beutler and D. Nemazee: Adjuvant-enhanced antibody responses in the absence of toll-like receptor signaling. Science, 314(5807), 1936-8 (2006)
32. D. Nemazee, A. Gavin, K. Hoebe and B. Beutler: Immunology: Toll-like receptors and antibody responses. Nature, 441(7091), E4; discussion E4 (2006) (Pubitemid 44050162)
33. A. Meyer-Bahlburg, S. Khim and D. J. Rawlings: B cell intrinsic TLR signals amplify but are not required for humoral immunity. J Exp Med, 204(13), 3095-101 (2007)
34. C. Picard, H. von Bernuth, P. Ghandil, M. Chrabieh, O. Levy, P. D. Arkwright, D. McDonald, R. S. Geha, H. Takada, J. C. Krause, C. B. Creech, C. L. Ku, S. Ehl, L. Marodi, S. Al-Muhsen, S. Al-Hajjar, A. Al-Ghonaium, N. K. Day-Good, S. M. Holland, J. I. Gallin, H. Chapel, D. P. Speert, C. Rodriguez-Gallego, E. Colino, B. Z. Garty, C. Roifman, T. Hara, H. Yoshikawa, S. Nonoyama, J. Domachowske, A. C. Issekutz, M. Tang, J. Smart, S. E. Zitnik, C. Hoarau, D. S. Kumararatne, A. J. Thrasher, E. G. Davies, C. Bethune, N. Sirvent, D. de Ricaud, Y. Camcioglu, J. Vasconcelos, M. Guedes, A. B. Vitor, C. Rodrigo, F. Almazan, M. Mendez, J. I. Arostegui, L. Alsina, C. Fortuny, J. Reichenbach, J. W. Verbsky, X. Bossuyt, R. Doffinger, L. Abel, A. Puel and J. L. Casanova: Clinical features and outcome of patients with IRAK-4 and MyD88 deficiency. Medicine (Baltimore), 89(6), 403-25 (2010)
35. C. L. Ku, H. von Bernuth, C. Picard, S. Y. Zhang, H. H. Chang, K. Yang, M. Chrabieh, A. C. Issekutz, C. K. Cunningham, J. Gallin, S. M. Holland, C. Roifman, S. Ehl, J. Smart, M. Tang, F. J. Barrat, O. Levy, D. McDonald, N. K. Day-Good, R. Miller, H. Takada, T. Hara, S. Al-Hajjar, A. Al-Ghonaium, D. Speert, D. Sanlaville, X. Li, F. Geissmann, E. Vivier, L. Marodi, B. Z. Garty, H. Chapel, C. Rodriguez-Gallego, X. Bossuyt, L. Abel, A. Puel and J. L. Casanova: Selective predisposition to bacterial infections in IRAK-4-deficient children: IRAK-4- dependent TLRs are otherwise redundant in protective immunity. J Exp Med, 204(10), 2407-22 (2007) (Pubitemid 47529326)
36. H. Chapel, M. Lucas, M. Lee, J. Bjorkander, D. Webster, B. Grimbacher, C. Fieschi, V. Thon, M. R. Abedi and L. Hammarstrom: Common variable immunodeficiency disorders: division into distinct clinical phenotypes. Blood, 112(2), 277-86 (2008)
37. L. D. Notarangelo, A. Fischer, R. S. Geha, J. L. Casanova, H. Chapel, M. E. Conley, C. Cunningham-Rundles, A. Etzioni, L. Hammartrom, S. Nonoyama, H. D. Ochs, J. Puck, C. Roifman, R. Seger and J. Wedgwood: Primary immunodeficiencies: 2009 update. J Allergy Clin Immunol, 124(6), 1161-78 (2009)
38. C. Cunningham-Rundles: Common variable immunodeficiency. Curr Allergy Asthma Rep, 1(5), 421-9 (2001)
39. K. Agematsu, T. Futatani, S. Hokibara, N. Kobayashi, M. Takamoto, S. Tsukada, H. Suzuki, S. Koyasu, T. Miyawaki, K. Sugane, A. Komiyama and H. D. Ochs: Absence of memory B cells in patients with common variable immunodeficiency. Clin Immunol, 103(1), 34-42 (2002) (Pubitemid 34478418)
40. K. Warnatz, A. Denz, R. Drager, M. Braun, C. Groth, G. Wolff-Vorbeck, H. Eibel, M. Schlesier and H. H. Peter: Severe deficiency of switched memory B cells (CD27(+)IgM(-)IgD(-)) in subgroups of patients with common variable immunodeficiency: a new approach to classify a heterogeneous disease. Blood, 99(5), 1544-51 (2002) (Pubitemid 34533024)
41. N. Taubenheim, M. von Hornung, A. Durandy, K. Warnatz, L. Corcoran, H. H. Peter and H. Eibel: Defined blocks in terminal plasma cell differentiation of common variable immunodeficiency patients. J Immunol, 175(8), 5498-503 (2005) (Pubitemid 41456437)
42. B. Grimbacher, A. Hutloff, M. Schlesier, E. Glocker, K. Warnatz, R. Drager, H. Eibel, B. Fischer, A. A. Schaffer, H. W. Mages, R. A. Kroczek and H. H. Peter: Homozygous loss of ICOS is associated with adult-onset common variable immunodeficiency. Nat Immunol, 4(3), 261-8 (2003) (Pubitemid 36322136)
43. M. C. van Zelm, I. Reisli, M. van der Burg, D. Castano, C. J. van Noesel, M. J. van Tol, C. Woellner, B. Grimbacher, P. J. Patino, J. J. van Dongen and J. L. Franco: An antibodydeficiency syndrome due to mutations in the CD19 gene. N Engl J Med, 354(18), 1901-12 (2006) (Pubitemid 43872691)
44. M. C. van Zelm, J. Smet, B. Adams, F. Mascart, L. Schandene, F. Janssen, A. Ferster, C. C. Kuo, S. Levy, J. J. van Dongen and M. van der Burg: CD81 gene defect in humans disrupts CD19 complex formation and leads to antibody deficiency. J Clin Invest, 120(4), 1265-74 (2010)
45. T. W. Kuijpers, R. J. Bende, P. A. Baars, A. Grummels, I. A. Derks, K. M. Dolman, T. Beaumont, T. F. Tedder, C. J. van Noesel, E. Eldering and R. A. van Lier: CD20 deficiency in humans results in impaired T cell-independent antibody responses. J Clin Invest, 120(1), 214-22 (2010)
46. K. Warnatz, U. Salzer, M. Rizzi, B. Fischer, S. Gutenberger, J. Bohm, A. K. Kienzler, Q. Pan-Hammarstrom, L. Hammarstrom, M. Rakhmanov, M. Schlesier, B. Grimbacher, H. H. Peter and H. Eibel: B-cell activating factor receptor deficiency is associated with an adult-onset antibody deficiency syndrome in humans. Proc Natl Acad Sci U S A, 106(33), 13945-50 (2009)
47. U. Salzer, H. M. Chapel, A. D. Webster, Q. Pan-Hammarstrom, A. Schmitt-Graeff, M. Schlesier, H. H. Peter, J. K. Rockstroh, P. Schneider, A. A. Schaffer, L. Hammarstrom and B. Grimbacher: Mutations in TNFRSF13B encoding TACI are associated with common variable immunodeficiency in humans. Nat Genet, 37(8), 820-8 (2005) (Pubitemid 41077107)
48. E. Castigli, S. A. Wilson, L. Garibyan, R. Rachid, F. Bonilla, L. Schneider and R. S. Geha: TACI is mutant in common variable immunodeficiency and IgA deficiency. Nat Genet, 37(8), 829-34 (2005) (Pubitemid 41077108)
49. S. Goldacker and K. Warnatz: Tackling the heterogeneity of CVID. Curr Opin Allergy Clin Immunol, 5(6), 504-9 (2005) (Pubitemid 41679984)
50. Q. Pan-Hammarstrom, U. Salzer, L. Du, J. Bjorkander, C. Cunningham-Rundles, D. L. Nelson, C. Bacchelli, H. B. Gaspar, S. Offer, T. W. Behrens, B. Grimbacher and L. Hammarstrom: Reexamining the role of TACI coding variants in common variable immunodeficiency and selective IgA deficiency. Nat Genet, 39(4), 429-30 (2007) (Pubitemid 46514756)
51. L. Zhang, L. Radigan, U. Salzer, T. W. Behrens, B. Grimbacher, G. Diaz, J. Bussel and C. Cunningham-Rundles: Transmembrane activator and calciummodulating cyclophilin ligand interactor mutations in common variable immunodeficiency: clinical and immunologic outcomes in heterozygotes. J Allergy Clin Immunol, 120(5), 1178-85 (2007) (Pubitemid 350047480)
52. U. Salzer, C. Bacchelli, S. Buckridge, Q. Pan-Hammarstrom, S. Jennings, V. Lougaris, A. Bergbreiter, T. Hagena, J. Birmelin, A. Plebani, A. D. Webster, H. H. Peter, D. Suez, H. Chapel, A. McLean-Tooke, G. P. Spickett, S. Anover-Sombke, H. D. Ochs, S. Urschel, B. H. Belohradsky, S. Ugrinovic, D. S. Kumararatne, T. C. Lawrence, A. M. Holm, J. L. Franco, I. Schulze, P. Schneider, E. M. Gertz, A. A. Schaffer, L. Hammarstrom, A. J. Thrasher, H. B. Gaspar and B. Grimbacher: Relevance of biallelic versus monoallelic TNFRSF13B mutations in distinguishing disease-causing from risk-increasing TNFRSF13B variants in antibody deficiency syndromes. Blood, 113(9), 1967-76 (2009)
53. R. F. Branda, A. L. Moore, R. Hong, J. J. McCormack, G. Zon and C. Cunningham-Rundles: B-cell proliferation and differentiation in common variable immunodeficiency patients produced by an antisense oligomer to the rev gene of HIV-1. Clin Immunol Immunopathol, 79(2), 115-21 (1996) (Pubitemid 26151411)
54. C. Cunningham-Rundles, L. Radigan, A. K. Knight, L. Zhang, L. Bauer and A. Nakazawa: TLR9 activation is defective in common variable immune deficiency. Journal of Immunology, 176(3), 1978-87 (2006) (Pubitemid 43134344)
55. D. Escobar, J. Pons, A. Clemente, J. Iglesias, V. Regueiro, J. A. Bengoechea, N. Matamoros and J. M. Ferrer: Defective B cell response to TLR9 ligand (CpG-ODN), Streptococcus pneumoniae and Haemophilus influenzae extracts in common variable immunodeficiency patients. Cell Immunol, 262(2), 105-11 (2010)
56. J. E. Yu, A. K. Knight, L. Radigan, T. U. Marron, L. Zhang, S. Sanchez-Ramon and C. Cunningham-Rundles: Tolllike receptor 7 and 9 defects in common variable immunodeficiency. J Allergy Clin Immunol, 124(2), 349-56, 356 e1-3 (2009)
57. M. Dorner, S. Brandt, M. Tinguely, F. Zucol, J. P. Bourquin, L. Zauner, C. Berger, M. Bernasconi, R. F. Speck and D. Nadal: Plasma cell toll-like receptor (TLR) expression differs from that of B cells, and plasma cell TLR triggering enhances immunoglobulin production. Immunology, 128(4), 573-9 (2009)
58. I. Douagi, C. Gujer, C. Sundling, W. C. Adams, A. Smed-Sorensen, R. A. Seder, G. B. Karlsson Hedestam and K. Lore: Human B cell responses to TLR ligands are differentially modulated by myeloid and plasmacytoid dendritic cells. J Immunol, 182(4), 1991-2001 (2009)
59. M. B. Litinskiy, B. Nardelli, D. M. Hilbert, B. He, A. Schaffer, P. Casali and A. Cerutti: DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL. Nat Immunol, 3(9), 822-9 (2002)
60. D. Braun, I. Caramalho and J. Demengeot: IFNalpha/ beta enhances BCR-dependent B cell responses. Int Immunol, 14(4), 411-9 (2002) (Pubitemid 34257768)
61. A. Cerutti, X. Qiao and B. He: Plasmacytoid dendritic cells and the regulation of immunoglobulin heavy chain class switching. Immunol Cell Biol, 83(5), 554-62 (2005) (Pubitemid 41805759)
62. G. Jego, A. K. Palucka, J. P. Blanck, C. Chalouni, V. Pascual and J. Banchereau: Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6. Immunity, 19(2), 225-34 (2003) (Pubitemid 37011337)
63. L. Giordani, M. Sanchez, I. Libri, M. G. Quaranta, B. Mattioli and M. Viora: IFN-alpha amplifies human naive B cell TLR-9-mediated activation and Ig production. J Leukoc Biol, 86(2), 261-71 (2009)
64. M. B. Uccellini, L. Busconi, N. M. Green, P. Busto, S. R. Christensen, M. J. Shlomchik, A. Marshak-Rothstein and G. A. Viglianti: Autoreactive B cells discriminate CpG-rich and CpG-poor DNA and this response is modulated by IFN-alpha. J Immunol, 181(9), 5875-84 (2008)
65. N. M. Green, A. Laws, K. Kiefer, L. Busconi, Y. M. Kim, M. M. Brinkmann, E. H. Trail, K. Yasuda, S. R. Christensen, M. J. Shlomchik, S. Vogel, J. H. Connor, H. Ploegh, D. Eilat, I. R. Rifkin, J. M. van Seventer and A. Marshak-Rothstein: Murine B cell response to TLR7 ligands depends on an IFN-beta feedback loop. J Immunol, 183(3), 1569-76 (2009)
66. J. C. Hall and A. Rosen: Type I interferons: crucial participants in disease amplification in autoimmunity. Nat Rev Rheumatol, 6(1), 40-9 (2010)
67. N. M. Green and A. Marshak-Rothstein: Toll-like receptor driven B cell activation in the induction of systemic autoimmunity. Semin Immunol, 23(2), 106-12 (2011)
68. B. Piqueras, C. Lavenu-Bombled, L. Galicier, F. Bergeron-van der Cruyssen, L. Mouthon, S. Chevret, P. Debre, C. Schmitt and E. Oksenhendler: Common variable immunodeficiency patient classification based on impaired B cell memory differentiation correlates with clinical aspects. J Clin Immunol, 23(5), 385-400 (2003) (Pubitemid 37083193)
69. C. Wehr, T. Kivioja, C. Schmitt, B. Ferry, T. Witte, E. Eren, M. Vlkova, M. Hernandez, D. Detkova, P. R. Bos, G. Poerksen, H. von Bernuth, U. Baumann, S. Goldacker, S. Gutenberger, M. Schlesier, F. Bergeronvan der Cruyssen, M. Le Garff, P. Debre, R. Jacobs, J. Jones, E. Bateman, J. Litzman, P. M. van Hagen, A. Plebani, R. E. Schmidt, V. Thon, I. Quinti, T. Espanol, A. D. Webster, H. Chapel, M. Vihinen, E. Oksenhendler, H. H. Peter and K. Warnatz: The EUROclass trial: defining subgroups in common variable immunodeficiency. Blood, 111(1), 77-85 (2008)
70. J. Ko, L. Radigan and C. Cunningham-Rundles: Immune competence and switched memory B cells in common variable immunodeficiency. Clin Immunol, 116(1), 37-41 (2005) (Pubitemid 40733581)
71. S. Sanchez-Ramon, L. Radigan, J. E. Yu, S. Bard and C. Cunningham-Rundles: Memory B cells in common variable immunodeficiency: clinical associations and sex differences. Clin Immunol, 128(3), 314-21 (2008)
72. H. Alachkar, N. Taubenheim, M. R. Haeney, A. Durandy and P. D. Arkwright: Memory switched B cell percentage and not serum immunoglobulin concentration is associated with clinical complications in children and adults with specific antibody deficiency and common variable immunodeficiency. Clin Immunol, 120(3), 310-8 (2006) (Pubitemid 44177779)
73. D. Detkova, J. de Gracia, S. Lopes-da-Silva, M. Vendrell, A. Alvarez, L. Guarner, A. Vidaller, M. J. Rodrigo, I. Caragol, T. Espanol and M. Hernandez: Common variable immunodeficiency: association between memory B cells and lung diseases. Chest, 131(6), 1883-9 (2007)
74. A. Marshak-Rothstein: Toll-like receptors in systemic autoimmune disease. Nat Rev Immunol, 6(11), 823-35 (2006) (Pubitemid 44631651)
75. M. Visentini, V. Conti, M. Cagliuso, F. Tinti, G. Siciliano, A. C. Trombetta, A. P. Mitterhofer, M. Fiorilli and I. Quinti: Regression of systemic lupus erythematosus after development of an acquired toll-like receptor signaling defect and antibody deficiency. Arthritis Rheum, 60(9), 2767-71 (2009)
76. I. Isnardi, Y. S. Ng, I. Srdanovic, R. Motaghedi, S. Rudchenko, H. von Bernuth, S. Y. Zhang, A. Puel, E. Jouanguy, C. Picard, B. Z. Garty, Y. Camcioglu, R. Doffinger, D. Kumararatne, G. Davies, J. I. Gallin, S. Haraguchi, N. K. Day, J. L. Casanova and E. Meffre: IRAK-4- and MyD88-dependent pathways are essential for the removal of developing autoreactive B cells in humans. Immunity, 29(5), 746-57 (2008)
77. O. C. Bruton: Agammaglobulinemia. Pediatrics, 9(6), 722-8 (1952)
78. M. E. Conley: B cells in patients with X-linked agammaglobulinemia. Journal of Immunology, 134(5), 3070-4 (1985)
79. S. Mahajan, A. Vassilev, N. Sun, Z. Ozer, C. Mao and F. M. Uckun: Transcription factor STAT5A is a substrate of Bruton's tyrosine kinase in B cells. Journal of Biological Chemistry, 276(33), 31216-28 (2001)
80. S. Middendorp, G. M. Dingjan, A. Maas, K. Dahlenborg and R. W. Hendriks: Function of Bruton's tyrosine kinase during B cell development is partially independent of its catalytic activity. Journal of Immunology, 171(11), 5988-96 (2003) (Pubitemid 37467217)
81. J. M. Lindvall, K. E. Blomberg, J. Valiaho, L. Vargas, J. E. Heinonen, A. Berglof, A. J. Mohamed, B. F. Nore, M. Vihinen and C. I. Smith: Bruton's tyrosine kinase: cell biology, sequence conservation, mutation spectrum, siRNA modifications, and expression profiling. Immunological Reviews, 203, 200-15 (2005) (Pubitemid 40185385)
82. J. A. Winkelstein, M. C. Marino, H. M. Lederman, S. M. Jones, K. Sullivan, A. W. Burks, M. E. Conley, C. Cunningham-Rundles and H. D. Ochs: X-linked agammaglobulinemia: report on a United States registry of 201 patients. Medicine (Baltimore), 85(4), 193-202 (2006) (Pubitemid 44107177)
83. C. I. Smith, B. Baskin, P. Humire-Greiff, J. N. Zhou, P. G. Olsson, H. S. Maniar, P. Kjellen, J. D. Lambris, B. Christensson, L. Hammarstrom and et al.: Expression of Bruton's agammaglobulinemia tyrosine kinase gene, BTK, is selectively down-regulated in T lymphocytes and plasma cells. J Immunol, 152(2), 557-65 (1994) (Pubitemid 24072959)
84. D. J. Rawlings, D. C. Saffran, S. Tsukada, D. A. Largaespada, J. C. Grimaldi, L. Cohen, R. N. Mohr, J. F. Bazan, M. Howard and N. G. Copeland: Mutation of unique region of Bruton's tyrosine kinase in immunodeficient XID mice. Science, 261(5119), 358-61 (1993) (Pubitemid 23281007)
85. A. Mangla, A. Khare, V. Vineeth, N. N. Panday, A. Mukhopadhyay, B. Ravindran, V. Bal, A. George and S. Rath: Pleiotropic consequences of Bruton tyrosine kinase deficiency in myeloid lineages lead to poor inflammatory responses. Blood, 104(4), 1191-7 (2004)
86. C. A. Jefferies, S. Doyle, C. Brunner, A. Dunne, E. Brint, C. Wietek, E. Walch, T. Wirth and L. A. O'Neill: Bruton's tyrosine kinase is a Toll/interleukin-1 receptor domain-binding protein that participates in nuclear factor kappaB activation by Toll-like receptor 4. Journal of Biological Chemistry, 278(28), 26258-64 (2003) (Pubitemid 36835395)
87. N. J. Horwood, T. H. Page, J. P. McDaid, C. D. Palmer, J. Campbell, T. Mahon, F. M. Brennan, D. Webster and B. M. Foxwell: Bruton's tyrosine kinase is required for TLR2 and TLR4-induced TNF, but not IL- 6, production. Journal of Immunology, 176(6), 3635-41 (2006) (Pubitemid 43364011)
88. S. L. Doyle, C. A. Jefferies, C. Feighery and L. A. O'Neill: Signaling by Toll-like receptors 8 and 9 requires Bruton's tyrosine kinase. Journal of Biological Chemistry, 282(51), 36953-60 (2007)
89. Y. Qiu and H. J. Kung: Signaling network of the Btk family kinases. Oncogene, 19(49), 5651-61 (2000)
90. M. Liljeroos, R. Vuolteenaho, S. Morath, T. Hartung, M. Hallman and M. Ojaniemi: Bruton's tyrosine kinase together with PI 3-kinase are part of Toll-like receptor 2 multiprotein complex and mediate LTA induced Toll-like receptor 2 responses in macrophages. Cellular Signalling, 19(3), 625-33 (2007) (Pubitemid 46107814)
91. N. W. Schmidt, V. T. Thieu, B. A. Mann, A. N. Ahyi and M. H. Kaplan: Bruton's tyrosine kinase is required for TLR-induced IL-10 production. Journal of Immunology, 177(10), 7203-10 (2006) (Pubitemid 44715089)
92. M. Hasan, G. Lopez-Herrera, K. E. Blomberg, J. M. Lindvall, A. Berglof, C. I. Smith and L. Vargas: Defective Toll-like receptor 9-mediated cytokine production in B cells from Bruton's tyrosine kinase-deficient mice. Immunology, 123(2), 239-49 (2008)
93. D. F. Amsbaugh, C. T. Hansen, B. Prescott, P. W. Stashak, D. R. Barthold and P. J. Baker: Genetic control of the antibody response to type 3 pneumococcal polysaccharide in mice. I. Evidence that an X-linked gene plays a decisive role in determining responsiveness. J Exp Med, 136(4), 931-49 (1972)
94. I. Scher: The CBA/N mouse strain: an experimental model illustrating the influence of the X-chromosome on immunity. Adv Immunol, 33, 1-71 (1982)
95. L. S. Wicker and I. Scher: X-linked immune deficiency (xid) of CBA/N mice. Curr Top Microbiol Immunol, 124, 87-101 (1986)
96. C. Kozlowski and D. I. Evans: Neutropenia associated with X-linked agammaglobulinaemia. J Clin Pathol, 44(5), 388-90 (1991)
97. J. E. Farrar, J. Rohrer and M. E. Conley: Neutropenia in X-linked agammaglobulinemia. Clinical Immunology & Immunopathology, 81(3), 271-6 (1996) (Pubitemid 26414555)
98. E. Halliday, J. Winkelstein and A. D. Webster: Enteroviral infections in primary immunodeficiency (PID): a survey of morbidity and mortality. J Infect, 46(1), 1-8 (2003) (Pubitemid 37266021)
99. N. J. Horwood, T. Mahon, J. P. McDaid, J. Campbell, H. Mano, F. M. Brennan, D. Webster and B. M. Foxwell: Bruton's tyrosine kinase is required for lipopolysaccharide-induced tumor necrosis factor alpha production. Journal of Experimental Medicine, 197(12), 1603-11 (2003) (Pubitemid 36745336)
100. K. Sochorova, R. Horvath, D. Rozkova, J. Litzman, J. Bartunkova, A. Sediva and R. Spisek: Impaired Tolllike receptor 8-mediated IL-6 and TNF-alpha production in antigen-presenting cells from patients with X-linked agammaglobulinemia. Blood, 109(6), 2553-6 (2007)
101. H. Taneichi, H. Kanegane, M. M. Sira, T. Futatani, K. Agematsu, M. Sako, H. Kaneko, N. Kondo, T. Kaisho and T. Miyawaki: Toll-like receptor signaling is impaired in dendritic cells from patients with X-linked agammaglobulinemia. Clinical Immunology, 126(2), 148-54 (2008)
102. R. Perez de Diego, E. Lopez-Granados, M. Pozo, C. Rodriguez, P. Sabina, A. Ferreira, G. Fontan, M. C. Garcia-Rodriguez and S. Alemany: Bruton's tyrosine kinase is not essential for LPS-induced activation of human monocytes. Journal of Allergy & Clinical Immunology, 117(6), 1462-9 (2006)
103. H. Jyonouchi, L. Geng, G. A. Toruner, K. Vinekar, D. Feng and P. Fitzgerald-Bocarsly: Monozygous twins with a microdeletion syndrome involving BTK, DDP1, and two other genes; evidence of intact dendritic cell development and TLR responses. Eur J Pediatr, 167(3), 317-21 (2008) (Pubitemid 351238209)
104. T. U. Marron, K. Rohr, M. Martinez-Gallo, J. Yu and C. Cunningham-Rundles: TLR signaling and effector functions are intact in XLA neutrophils. Clin Immunol, 137(1), 74-80 (2010)
105. A. M. Avalos, L. Busconi and A. Marshak-Rothstein: Regulation of autoreactive B cell responses to endogenous TLR ligands. Autoimmunity, 43(1), 76-83 (2009)
106. E. J. Hennessy, A. E. Parker and L. A. O'Neill: Targeting Toll-like receptors: emerging therapeutics? Nat Rev Drug Discov, 9(4), 293-307 (2010)